Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.46 - $0.78 $1,911 - $3,241
4,156 Added 35.7%
15,798 $8,000
Q1 2024

May 15, 2024

BUY
$0.48 - $0.85 $2,813 - $4,981
5,861 Added 101.38%
11,642 $8,000
Q4 2023

Feb 13, 2024

BUY
$0.38 - $0.82 $988 - $2,132
2,600 Added 81.74%
5,781 $4,000
Q3 2023

Nov 14, 2023

BUY
$0.65 - $1.04 $2,067 - $3,308
3,181 New
3,181 $2,000
Q2 2022

Aug 15, 2022

SELL
$1.07 - $1.55 $9,458 - $13,702
-8,840 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.21 - $2.24 $5,130 - $9,497
4,240 Added 92.17%
8,840 $13,000
Q4 2021

Feb 14, 2022

BUY
$2.02 - $3.36 $1,519 - $2,526
752 Added 19.54%
4,600 $10,000
Q3 2021

Nov 15, 2021

BUY
$2.96 - $36.67 $9,643 - $119,470
3,258 Added 552.2%
3,848 $12,000
Q2 2021

Aug 16, 2021

SELL
$31.5 - $42.5 $1,669 - $2,252
-53 Reduced 8.24%
590 $20,000
Q1 2021

May 17, 2021

BUY
$25.01 - $40.24 $16,081 - $25,874
643 New
643 $22,000
Q4 2020

Feb 16, 2021

SELL
$28.66 - $46.79 $57,234 - $93,439
-1,997 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$14.71 - $50.69 $16,872 - $58,141
1,147 Added 134.94%
1,997 $97,000
Q2 2020

Aug 13, 2020

BUY
$13.9 - $24.6 $11,815 - $20,910
850 New
850 $12,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.